Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBX-2982 in Type 2 Diabetes
NCT01035879Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of mbx-2982 in type 2 diabetes mellitus (T2DM), sponsored by Gilead Sciences. Started Dec 2009; status: completed.
02
Drugs
mbx-2982
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01035879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01035879.